Effect of Hareetakyadi Anjana in Kaphaja Timira(Immature Cataract)

An open label single arm prospective clinical study on Hareetakyadi Anjana in Kaphaja Timira(Immature Cataract)

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/08/015205

Enrollment

Registered

2018-08-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Immature Cataract

Interventions

Intervention1: Hareetakyadi Anjana: Dose-1 drop BD Administrative route-topical eyedrop Duration- for 2 months Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Immature cataract

Exclusion criteria

Exclusion criteria: Senile Mature Cataract. Hypermature Cataract. congenital,Traumatic,Developmental,Complicated or Metabolic Cataracts. Other ocular pathologies which cause diminision of vision.

Design outcomes

Primary

Measure	Time frame
visual Acuity for distance and near Grade of cataractTimepoint: every 15 days for 2 months	—

Secondary

Measure	Time frame
Glare Floaters DiplopiaTimepoint: 2 months	—

Countries

India

Contacts

Public ContactGreeshma Menon

SDM College of Ayurveda and Hospital,Hassan

drashwinimj@sdmcahhassan.org9448222694

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026